BD receives CEO Cancer Gold Standard accreditation

BD (Becton, Dickinson and Company) has received CEO Cancer Gold Standard^™ accreditation, recognizing the company's commitment to reducing cancer risk by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment for its own employees and their covered family members.

Christopher A. Viehbacher, chief executive officer of Sanofi, chairs the CEO Roundtable on Cancer, a nonprofit organization of cancer-fighting CEOs who created the CEO Cancer Gold Standard^™, in collaboration with the National Cancer Institute, many of its designated cancer centers, and leading health non-profit organizations and professionals. Today, more than two million employees and family members are benefiting from the vision and leadership of employers like BD who have chosen to become Gold Standard accredited.

"This Gold Standard accreditation is an acknowledgement of BD's leadership by example and the organization's commitment to health, starting with the health of BD's employees and their family members," said Christopher A. Viehbacher, CEO of Sanofi. "I hope BD's commitment will encourage other employers, large and small, to become Gold Standard accredited."